kw 2189 has been researched along with Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adjei, AA; Alberts, SR; Braich, TA; Creagan, ET; Fitch, TR; Hillman, DW; Kaur, JS; Leitch, JM; Markovic, SN; Suman, VJ; Vukov, AM | 1 |
1 trial(s) available for kw 2189 and Melanoma
| Article | Year |
|---|---|
Phase II trial of KW2189 in patients with advanced malignant melanoma.
Topics: Antibiotics, Antineoplastic; Duocarmycins; Humans; Melanoma; Pyrrolidinones; Survival Rate | 2002 |